573 related articles for article (PubMed ID: 6153392)
1. Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.
Powars DR; Schroeder WA; Weiss JN; Chan LS; Azen SP
J Clin Invest; 1980 Mar; 65(3):732-40. PubMed ID: 6153392
[TBL] [Abstract][Full Text] [Related]
2. The interaction of alpha-thalassemia and homozygous sickle-cell disease.
Higgs DR; Aldridge BE; Lamb J; Clegg JB; Weatherall DJ; Hayes RJ; Grandison Y; Lowrie Y; Mason KP; Serjeant BE; Serjeant GR
N Engl J Med; 1982 Jun; 306(24):1441-6. PubMed ID: 6176865
[TBL] [Abstract][Full Text] [Related]
3. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
Embury SH; Dozy AM; Miller J; Davis JR; Kleman KM; Preisler H; Vichinsky E; Lande WN; Lubin BH; Kan YW; Mentzer WC
N Engl J Med; 1982 Feb; 306(5):270-4. PubMed ID: 6172710
[TBL] [Abstract][Full Text] [Related]
4. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
[TBL] [Abstract][Full Text] [Related]
5. Pain in sickle cell disease. Rates and risk factors.
Platt OS; Thorington BD; Brambilla DJ; Milner PF; Rosse WF; Vichinsky E; Kinney TR
N Engl J Med; 1991 Jul; 325(1):11-6. PubMed ID: 1710777
[TBL] [Abstract][Full Text] [Related]
6. The relationship between fetal hemoglobin and disease severity in children with sickle cell anemia.
Odenheimer DJ; Sarnaik SA; Whitten CF; Rucknagel DL; Sing CF
Am J Med Genet; 1987 Jul; 27(3):525-35. PubMed ID: 2443006
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
Charache S
Semin Hematol; 1997 Jul; 34(3 Suppl 3):15-21. PubMed ID: 9317197
[TBL] [Abstract][Full Text] [Related]
8. Mortality in sickle cell disease. Life expectancy and risk factors for early death.
Platt OS; Brambilla DJ; Rosse WF; Milner PF; Castro O; Steinberg MH; Klug PP
N Engl J Med; 1994 Jun; 330(23):1639-44. PubMed ID: 7993409
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
10. Acute splenic sequestration in female children with sickle cell disease in the North of Jordan.
Al-Rimawi HS; Abdul-Qader M; Jallad MF; Amarin ZO
J Trop Pediatr; 2006 Dec; 52(6):416-20. PubMed ID: 16951418
[TBL] [Abstract][Full Text] [Related]
11. The effect of fetal hemoglobin on the sickling dynamics of SS erythrocytes.
Sewchand LS; Johnson CS; Meiselman HJ
Blood Cells; 1983; 9(1):147-66. PubMed ID: 6190521
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of sickle cell disease as shown by density profiles: effects of fetal hemoglobin and alpha thalassemia.
Baudin V; Pagnier J; Labie D; Girot R; Wajcman H
Haematologia (Budap); 1986; 19(3):177-84. PubMed ID: 2430866
[TBL] [Abstract][Full Text] [Related]
13. The influence of foetal haemoglobin on the frequency of vaso-occlusive crisis in sickle cell anaemia patients.
Enosolease ME; Ejele OA; Awodu OA
Niger Postgrad Med J; 2005 Jun; 12(2):102-5. PubMed ID: 15997258
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyurea therapy for diverse pediatric populations with sickle cell disease.
Rogers ZR
Semin Hematol; 1997 Jul; 34(3 Suppl 3):42-7. PubMed ID: 9317200
[TBL] [Abstract][Full Text] [Related]
15. Foetal haemoglobin levels in sickle cell anaemia in Nigerians.
Falusi AG; Esan GJ
Afr J Med Med Sci; 1989 Jun; 18(2):145-9. PubMed ID: 2474239
[TBL] [Abstract][Full Text] [Related]
16. Red cell distribution width in sickle cell disease.
Webster P; Castro O
Ann Clin Lab Sci; 1986; 16(4):274-7. PubMed ID: 3740796
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin F concentration as a function of age in Kuwaiti sickle cell disease patients.
Adekile A; Al-Kandari M; Haider M; Rajaa M; D'Souza M; Sukumaran J
Med Princ Pract; 2007; 16(4):286-90. PubMed ID: 17541294
[TBL] [Abstract][Full Text] [Related]
18. The presence of alpha-thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease.
Vasavda N; Badiger S; Rees D; Height S; Howard J; Thein SL
Br J Haematol; 2008 Nov; 143(4):589-92. PubMed ID: 18764867
[TBL] [Abstract][Full Text] [Related]
19. Sickle cell anaemia in Nigeria: a comparison between Benin and Lagos.
Akenzua G; Akinyanju O; Kulozik A; Whitehead S; Morris J; Serjeant BE; Serjeant G
Afr J Med Med Sci; 1994 Jun; 23(2):101-7. PubMed ID: 7542830
[TBL] [Abstract][Full Text] [Related]
20. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
